COVID-19 has shifted the focus to biotech and genetic interventions, and this offers an appropriate opportunity to work on strategic research outcomes which are specifically India-centric, Union Minister Jitendra Singh has said.
Addressing scientists and officials of the Department of Biotechnology (DBT) in his first review meeting on Friday after taking charge as the science and technology minister, Singh said India has huge resource material for research.
It can offer the world exclusive preventive and therapeutic options, particularly considering the fact that Indian phenotype and genotype are different from the rest of the world, he said.